Trial Profile
Correlation of Dasatinib Pharmacokinetics with Clinical Response and Adverse Events in Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacogenomic; Pharmacokinetics
- 31 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.